Showing 4661-4670 of 7938 results for "".
- Most Indoor Tanning Salons in Texas Do Comply with Tanning Bans for Minorshttps://practicaldermatology.com/news/most-indoor-tanning-salons-in-texas-do-comply-with-tanning-bans-for-minors/2458378/Most indoor tanning salons comply with Texas’ tanning ban for those under 18, new research suggests. When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor ta
- Precision Medicine in Action: Clinical Features May Help ID High Risk Melanoma Patientshttps://practicaldermatology.com/news/precision-medicine-in-action-clinical-featires-may-help-id-high-risk-melanoma-patients/2458379/Zeroing in on an individual’s risk factors for melanoma can help identify high-risk patients who may benefit from increased surveillance, new research suggests. Caroline G. Watts, M.P.H., of the University of Sydney, Australia, and coauthors examined clinical features associated wit
- Can IL-33 Blockade Ease Severe Poison Ivy Itch? Mouse Study Says Maybehttps://practicaldermatology.com/news/can-il-33-blockers-ease-severe-poison-ivy-itch/2458382/Blocking interleukin 33 (IL-33) may put the brakes on the uncontrollable itch caused by poison ivy, poison sumac, poison oak and even mango trees, according to a mouse study conducted by scientists at Duke Health in Durham, NC, and Zhejiang Chinese Medical University in China. The r
- New Interim CEO Named For Canada's Crescitahttps://practicaldermatology.com/news/new-interim-ceo-for-canadas-crescita/2458386/Dan Chicoine is now the interim Chief Executive Officer of Crescita Therapeutics Inc., a commercial dermatology company in Canada. He is replacing Greg Orleski. Mr. Chicoine will also continue to serve as the Company's Executive
- Study Calls Attention to Negative Impact, Need for Treatment of SKhttps://practicaldermatology.com/news/study-calls-attention-to-negative-impact-need-for-treatment-of-sk/2458393/Patients with asymptomatic seborrheic keratosis (SK) are bothered by highly visible skin lesions and are very interested in treatment to improve their appearance, even if a cost were associated with treatment, according to a new study conducted in dermatology practices by Burke, Inc. on behalf of
- Dr. Ken Washenik Named New President of International Society of Hair Restoration Surgeryhttps://practicaldermatology.com/news/dr-ken-washenik-named-new-president-of-international-society-of-hair-restoration-surgery/2458394/The International Society of Hair Restoration Surgery (ISHRS), a global non-profit medical association and a leading authority on hair loss treatment and restoration, elected Ken Washenik, MD, PhD, FISHRS, as President. The announcement took place at the ISHRS 24th</
- FDA Clears Merz Aesthetics' Cellfina System for Long-Term Improvement of Cellulitehttps://practicaldermatology.com/news/fda-clears-merz-aesthetics-cellfina-system-for-long-term-improvement-of-cellulite/2458399/The FDA has cleared the Cellfina System from Merz Aesthetics, a division of Merz North America, for the long-term improvement in the appearance of cellulite on the buttocks and thighs of adult females with no loss of benefit for up to 3 years. Cellfina is the only FDA-cleared minimally in
- New from NeoStrata: Introducing the ProSystem Retinol Peelhttps://practicaldermatology.com/news/new-from-neostrata-the-prosystem-retinol-peel/2458398/NeoStrata is rolling out the NeoStrata ProSystem Retinol Peel, the first retinol peel for the brand. The peel contains 3% Retinol plus Retinol Boosting Complex to exfoliate and improve the appearance of fine lines and wrinkles, help reduce acne,
- Biosim Update: Pfizer to Begin Shipping INFLECTRA in Late November 2016https://practicaldermatology.com/news/biosim-update-pfizer-to-begin-shipping-inflectra-in-late-november-2016/2458400/Pfizer Inc. will begin shipment of INFLECTRA (infliximab-dyyb) for injection, a biosimilar of REMICADE1 (infliximab) to wholesalers in the United States in late November 2016. INFLECTRA will be the first biosimilar mono
- Encore Dermatology Introduces HylatopicPlus® Lotionhttps://practicaldermatology.com/news/encore-dermatology-introduces-hylatopicplus-lotion/2458402/Encore Dermatology, Inc. is expanding its line to with HylatopicPlus® Lotion in a 14 oz. bottle with pump dispenser. The Rx product relieves the burning, itching and pain experienced with various types of skin conditions, includi